Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

ClinicalTrials.gov ID: NCT02449239

Public ClinicalTrials.gov record NCT02449239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 28, 2026, 7:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label, Multicenter, Ph 3 [Phase 3] Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Subjects With Non Muscle-Invasive Carcinoma in Situ and/or High-Grade Papillary Disease of the Bladder Treated With BCG

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Because of the high risk for development of muscle invasive disease, cystectomy is recommended for CIS, high-grade Ta and T1 patients who experience disease recurrence following intravesical therapy. Vicinium is an experimental agent that may provide an alternative to cystectomy

Study identification

NCT ID: NCT02449239
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Sesen Bio, Inc.; Industry
Enrollment: 133 participants

Conditions and interventions

Conditions

Bladder Cancer

Interventions

Vicinium Biological

Biological

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2015 (Type not available)
Primary completion: May 2020 (Actual)
Completion: May 2022 (Actual)
Last update posted: Jul 24, 2023

2015 – 2022

United States locations

U.S. sites: 61
U.S. states: 29
U.S. cities: 56

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35294	—
Not listed	Phoenix	Arizona	85032	—
Not listed	Tucson	Arizona	85741	—
Not listed	Little Rock	Arkansas	72211	—
Not listed	Los Angeles	California	90017	—
Not listed	Los Angeles	California	90048	—
Not listed	Los Angeles	California	90089	—
Not listed	Los Angeles	California	90095	—
Not listed	Redwood City	California	94062	—
Not listed	San Bernardino	California	92404	—
Not listed	Sherman Oaks	California	91411	—
Not listed	Torrance	California	90505	—
Not listed	Englewood	Colorado	80113	—
Not listed	Washington D.C.	District of Columbia	20010	—
Not listed	Bradenton	Florida	34205	—
Not listed	Daytona Beach	Florida	32114	—
Not listed	Orlando	Florida	32803	—
Not listed	St. Petersburg	Florida	33710	—
Not listed	Tampa	Florida	33612	—
Not listed	Wellington	Florida	33449	—
Not listed	Atlanta	Georgia	30322	—
Not listed	Honolulu	Hawaii	96813	—
Not listed	Coeur d'Alene	Idaho	83814	—
Not listed	Meridian	Idaho	83642	—
Not listed	Lake Barrington	Illinois	60010	—
Not listed	Jeffersonville	Indiana	47130	—
Not listed	Fairway	Kansas	66205	—
Not listed	Lenexa	Kansas	66214	—
Not listed	Wichita	Kansas	67208	—
Not listed	New Orleans	Louisiana	70112	—
Not listed	Glen Burnie	Maryland	21061	—
Not listed	Boston	Massachusetts	02111	—
Not listed	Burlington	Massachusetts	01805	—
Not listed	Worcester	Massachusetts	01655	—
Not listed	Ann Arbor	Michigan	48109	—
Not listed	Lebanon	New Hampshire	03756	—
Not listed	Brick	New Jersey	08724	—
Not listed	Lawrenceville	New Jersey	08648	—
Not listed	Morristown	New Jersey	07960	—
Not listed	Albuquerque	New Mexico	87109	—
Not listed	Albany	New York	12208	—
Not listed	New York	New York	10032	—
Not listed	Poughkeepsie	New York	12601	—
Not listed	Syracuse	New York	13210	—
Not listed	The Bronx	New York	10461	—
Not listed	Concord	North Carolina	28025	—
Not listed	Middleburg Heights	Ohio	44130	—
Not listed	Oklahoma City	Oklahoma	73014	—
Not listed	Portland	Oregon	97239	—
Not listed	Bala-Cynwyd	Pennsylvania	19004	—
Not listed	Bryn Mawr	Pennsylvania	19010	—
Not listed	Pittsburgh	Pennsylvania	15232	—
Not listed	Charleston	South Carolina	29401	—
Not listed	Charleston	South Carolina	29425	—
Not listed	Dallas	Texas	75231	—
Not listed	El Paso	Texas	79920	—
Not listed	Houston	Texas	68130	—
Not listed	Houston	Texas	77030	—
Not listed	Temple	Texas	76508	—
Not listed	Charlottesville	Virginia	22908	—
Not listed	Richmond	Virginia	23235	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02449239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 24, 2023 · Synced Oct 28, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02449239 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →